Thyroglobulin, calcitonin, and CEA (carcinoembryonic antigen) are tumor markers that can be useful in the management and monitoring of anaplastic thyroid carcinoma (ATC), although their specific utility may vary depending on the patient and other individual disease characteristics. This evidence concerns the gene CALCA and neoplasm.